Cargando…
Homocysteine and Lp-PLA2 levels: Diagnostic value in coronary heart disease
Coronary heart disease (CHD) is the leading cause of mortality worldwide. Identifying effective diagnostic markers and understanding risk factors is crucial for prevention and management. This study aimed to investigate the levels of homocysteine (Hcy) and lipoprotein-associated phospholipase A2 (Lp...
Autores principales: | Wu, Linlin, Shao, Peng, Gao, Zhanyi, Zhang, Shan, Ma, Jiahui, Bai, Jie, Wei, Yuejuan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10659678/ https://www.ncbi.nlm.nih.gov/pubmed/37986337 http://dx.doi.org/10.1097/MD.0000000000035982 |
Ejemplares similares
-
Elevated homocysteine levels in patients with heart failure: A systematic review and meta-analysis
por: Jin, Nake, et al.
Publicado: (2021) -
The association between levels of serum homocysteine and chronic heart failure: A protocol for systematic review and meta-analysis
por: Wang, Xi, et al.
Publicado: (2021) -
Serum IMA and LP-PLA2 Levels in Patients with Coronary Heart Disease and Their Correlation with the Degree of Myocardial Ischaemia and Their Diagnostic Value
por: Zhang, Likui, et al.
Publicado: (2022) -
Association Lp-PLA2 Gene Polymorphisms with Coronary Heart Disease
por: Ma, Sha, et al.
Publicado: (2022) -
Value of plasma homocysteine to predict stroke, cardiovascular diseases, and new-onset hypertension: A retrospective cohort study
por: Feng, Yuanyuan, et al.
Publicado: (2020)